Kidney disease is one of the leading complications of diabetes, and can lead to serious health problems, including the need for dialysis or kidney transplant. Despite many medical advances that have improved diabetes treatment, kidney disease remains a problem for many people with diabetes. New treatments are urgently needed.
PERL is a clinical trial for people with type 1 diabetes who have early signs of kidney problems. Our goal is to test a new way to reduce loss of kidney function using a safe and inexpensive medicine. Over 1500 people with type 1 diabetes volunteered to participate in the PERL study, and 530 were eligible and enrolled in the study. PERL will be completed in Summer 2019.
To learn more about PERL, click on the tabs above.